More recently, metformin can induce STING expression in pancreatic cancer and activate the STING/IRF3/IFN-β pathway by inhibiting AKT signaling in pancreatic ductal adenocarcinoma (Ren et al., 2020). This evidence concerns the gene STING1 and pancreatic neoplasm.